Prehospital Thrombolytic Therapy in Patients with Suspected Acute Myocardial Infarction

New England Journal of Medicine

Volumn 329, Issue 6, 1993, Pages 383-389

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANISTREPLASE; PLACEBO;

ADULT; AGED; ARTICLE; BLEEDING; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART VENTRICLE FIBRILLATION; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; SHOCK; STROKE;

AGED; ANISTREPLASE; CANADA; DOUBLE-BLIND METHOD; EUROPE; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; ODDS RATIO; SUPPORT, NON-U.S. GOV'T; THROMBOLYTIC THERAPY;

EID: 0027275109     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199308053290602     Document Type: Article

References (30)

1. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 1987; 2: 871-874
2. AIMS Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1988; 1: 545-549
3. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-360
4. Boissel JP, Leizorovicz A. Pre-hospital thrombolysis: a challenge? In: Sleight P, Chamberlain DA, eds. Thrombolysis: the dawn of a new era. London: IBC Technical Services, 1990:96-108.
5. Koren G, Weiss AT, Hasin Y, Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med 1985; 313: 1384-1389
6. Applebaum D, Weiss AT, Koren G, Ben David Y, Hasin Y, Gotsmann MS Feasibility of pre-hospital fibrinolytic therapy in acute myocardial infarction. Am J Emerg Med 1986; 4: 201-204
7. Bippus P-H, Haux R, Schroder R Praehospital intravenous streptokinase in evolving myocardial infarction: a randomised study about feasibility, safety, and time-gain. Eur Heart J 1987; 8: Suppl 2: 103-103 abstract.
8. Weiss AT, Fine DG, Applebaum D, Prehospital coronary thrombolysis: a new strategy in acute myocardial infarction. Chest 1987; 92: 124-128
9. Bossaert LL, Demey HE, Colemont LJ, Prehospital thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. Crit Care Med 1988; 16: 823-830
10. Castaigne AD, Herve C, Duval-Moulin AM, Prehospital use of APSAC: results of a placebo-controlled study. Am J Cardiol 1989; 64: 30A-33A
11. Barbash GI, Roth A, Hod H, Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction. Am J Cardiol 1990; 66: 261-266
12. Roth A, Barbash GI, Hod H, Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. J Am Coll Cardiol 1990; 15: 932-936
13. Schofer J, Buttner J, Geng G, Prehospital thrombolysis in acute myocardial infarction. Am J Cardiol 1990; 66: 1429-1433
14. The Thrombolysis Early in Acute Heart Attack Trial Study Group. Very early thrombolytic therapy in suspected acute myocardial infarction. Am J Cardiol 1990; 65: 401-407
15. Weaver WD, Eisenberg MS, Martin JS, Myocardial Infarction Triage and Intervention Project -- phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy. J Am Coll Cardiol 1990; 15: 925-931
16. BEPS Collaborative Group. Prehospital thrombolysis in acute myocardial infarction: the Belgian eminase prehospital study (BEPS). Eur Heart J 1991; 12: 965-967
17. O'Rourke M, Gallagher D, Healey J, Paramedic-initiated pre-hospital thrombolysis using urokinase in acute coronary occlusion (T.I.C.O.2). J Am Coll Cardiol 1991; 17: Suppl A: 246A-246A abstract.
18. The European Myocardial Infarction Project (E.M.I.P.). Potential time saving with pre-hospital intervention in acute myocardial infarction: report of the European Myocardial Infarction Project (E.M.I.P.) sub-committee. Eur Heart J 1988; 9: 118-124
19. Boissel JP, Peyrieux JC Simulation-based sample size estimate. Control Clin Trials 1988; 9: 285-285 abstract.
20. Boissel JP, Sacks HS, Leizorovicz A, Blanchard J, Panak E, Peyrieux JC Meta-analysis of clinical trials: summary of an international conference. Eur J Clin Pharmacol 1988; 34: 535-538
21. Fleiss JL. Statistical methods for rates and proportions. New York: Wiley, 1973.
22. GREAT Group. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. BMJ 1992; 305: 548-553
23. Weaver DW, Cerqueira M, Halstrom AP, et al. The Myocardial Infarction Triage and Intervention Trial of pre-hospital versus hospital initiated thrombolytic therapy. JAMA (in press).
24. Kereiakes DJ, Weaver WD, Anderson JL, Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities: report from the Pre-hospital Study Group and the Cincinnati Heart Project. Am Heart J 1990; 120: 773-780
25. Martin JS, Novotny-Dinsdale V, Jensen SK, Litwin PE, Weaver WD Early triage and treatment of the acute myocardial infarction patient: how fast is fast? J Emerg Nurs 1990; 16: 195-202
26. MacCallum AG, Stafford PJ, Jones C, Vincent R, Perez-Avila C, Chamberlain DA Reduction in hospital time to thrombolytic therapy by audit of policy guidelines. Eur Heart J 1990; 11: Suppl F: 48-52
27. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction. Lancet 1992; 339: 753-770
28. Meinertz T, Kasper W, Schumacher M, Just H The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction. Am J Cardiol 1988; 62: 347-351
29. Wilcox RG, von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet 1988; 2: 525-530
30. The I.S.A.M. Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.): mortality, morbidity, and infarct size at 21 days. N Engl J Med 1986; 314: 1465-1471